Table 2.
Distributions of risk factors (percentages) for men and women for eight trials of antihypertensive treatment
| Women (n=20 802) | Men (n=27 987) | |
|---|---|---|
| Age (years): | ||
| <35 | 1.6 | 1.5 |
| 35-39 | 4.2 | 8.5 |
| 40-44 | 7.0 | 13.2 |
| 45-49 | 10.5 | 18.2 |
| 50-54 | 13.9 | 18.8 |
| 55-59 | 13.9 | 13.1 |
| 60-64 | 14.0 | 8.6 |
| 65-69 | 12.2 | 7.7 |
| 70-74 | 13.7 | 6.9 |
| ⩾75 | 9.1 | 3.4 |
| Systolic blood pressure (mm Hg): | ||
| <120 | 0.2 | 1.4 |
| 120-129 | 1.4 | 6.5 |
| 130-139 | 4.9 | 14.7 |
| 140-149 | 9.4 | 19.0 |
| 150-159 | 11.6 | 15.7 |
| 160-169 | 21.8 | 17.1 |
| 170-179 | 17.7 | 11.3 |
| 180-189 | 14.2 | 7.1 |
| 190-199 | 9.9 | 4.1 |
| 200-210 | 5.5 | 2.1 |
| ⩾210 | 3.4 | 1.0 |
| Cholesterol concentration (mmol/l): | ||
| <5.0 | 8.3 | 11.1 |
| 5.0-5.9 | 25.3 | 31.6 |
| 6.0-6.9 | 32.9 | 35.6 |
| 7.0-7.9 | 21.8 | 16.5 |
| 8.0-8.9 | 8.2 | 4.3 |
| ⩾9.0 | 3.5 | 0.8 |
| Height (m): | ||
| <1.50 | 6.9 | 0.3 |
| 1.50-1.59 | 40.6 | 1.9 |
| 1.60-1.69 | 45.7 | 23.0 |
| 1.70-1.79 | 6.6 | 52.8 |
| 1.80-1.89 | 0.2 | 20.8 |
| ⩾1.90 | 0 | 1.3 |
| Creatinine concentration (μmol/l): | ||
| <60 | 4.5 | 0.02 |
| 60-69 | 13.7 | 1.1 |
| 70-79 | 24.5 | 9.2 |
| 80-89 | 22.2 | 19.3 |
| 90-99 | 16.8 | 24.9 |
| 100-109 | 8.9 | 19.6 |
| 110-119 | 4.4 | 12.3 |
| 120-129 | 2.2 | 6.6 |
| ⩾130 | 2.9 | 6.7 |
| Current cigarette smoker | 22.9 | 37.9 |
| Previous myocardial infarction | 2.5 | 4.7 |
| Previous stroke | 1.2 | 1.0 |
| History of diabetes | 3.8 | 3.2 |
| Left ventricular hypertrophy | 11.2 | 13.2 |